| 1 |
Gary Trewartha |
Astex Therapeutics Limited |
3 |
| 2 |
Richard O'Dell |
Cambridge Display Technology Limited |
2 |
| 2 |
Ian A. Parks |
Xerox |
2 |
| 2 |
Bruce MacMichael |
Powderject Research Limited |
2 |
| 2 |
Shaun Christopher Hazlewood |
Diagnostics For The Real World |
2 |
| 2 |
Gary Stuart Wallace |
Ford |
2 |
| 2 |
Sally Oxenford |
Genentech |
2 |
| 2 |
Peter Saunderson |
3Com Technologies |
2 |
| 2 |
William James Templeton-Steadman |
Zi Corporation Of Canada |
2 |
| 2 |
David J. Pearce |
Xerox |
2 |
| 2 |
James Richard Burfiend |
The Procter & Gamble |
2 |
| 2 |
Simon Ellis |
Adc Gmbh |
2 |
| #13 |
Vincenzo Costanzo |
Oregon Health & Science University |
1 |
| #13 |
Neil Cole |
Qinetiq Limited |
1 |
| #13 |
David Winterburn |
Xtera Communications |
1 |
| #13 |
Caroline Russell |
Pfizer |
1 |
| #13 |
Arthur Dabrowski |
E.I. Du Pont De Nemours And |
1 |
| #13 |
Mark Anthony Clarke |
Unknown |
1 |
| #13 |
Michael Beadman |
Esselte N.V. |
1 |
| #13 |
Brian Rowatt |
Sun Chemical |
1 |
| #13 |
Martin Roantree |
Xerox |
1 |
| #13 |
Mrinalini Sachin Oza |
Novartis Ag |
1 |
| #13 |
Paul Barraclough |
Phytopharm Plc |
1 |
| #13 |
Philip Alan Skone |
Glaxo Group Limited |
1 |
| #13 |
Kevin Christopher Hackett |
Qinetiq Limited |
1 |
| #13 |
Andrew J. Garrett |
IBM |
1 |
| #13 |
Daxa Neykumar Rughani |
Ffei Limited |
1 |
| #13 |
Corinne Dive-Reclus |
Nokia |
1 |
| #13 |
Douglas Ivan Jennings |
Sanofi-Aventis |
1 |